Detalhe da pesquisa
1.
Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease.
Br J Clin Pharmacol
; 82(2): 352-61, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27038001
2.
The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development.
Am Heart J
; 165(4): 489-500, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23537964
3.
Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects.
Clin Drug Investig
; 37(11): 1035-1045, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28856602
4.
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention.
J Am Heart Assoc
; 6(4)2017 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356282
5.
Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot Study.
Circ Cardiovasc Interv
; 8(7): e002232, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26152562
6.
A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.
J Clin Pharmacol
; 44(9): 1063-71, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15317834
7.
Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study.
Diabetes Ther
; 2(3): 123-32, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22127822